Janus tyrosine kinase (JAK) signaling may be involved in the pathogenesis of polymyalgia rheumatica (PMR), and tofacitinib may be an effective treatment, according to a pilot study published online June 29 in PLOS Medicine.
Jul 10, 2023
0
0
China is facing renewed allegations that the COVID-19 outbreak was caused by a leak from one of their laboratories—and that this research is connected to biowarfare.
Jun 15, 2023
0
13
For patients with adenomyosis, mifepristone is efficacious and has acceptable tolerability, according to a study published online June 12 in JAMA Network Open.
Jun 14, 2023
0
2
For patients with stroke of recent onset or progression of stroke symptoms and no occlusion of large or medium-sized cerebral vessels, intravenous tirofiban is associated with an increased likelihood of an excellent outcome, ...
Jun 5, 2023
0
15
Triple semicircular canal plugging (TSCP) is comparable to labyrinthectomy for the control of vertigo with Meniere disease (MD) while better preserving hearing, according to a study published online April 10 in Laryngoscope.
May 8, 2023
0
2
For patients with hepatitis B virus (HBV) liver cirrhosis-acute decompensation (LC-AD), a model combining computed tomography (CT) quantified extracellular liver volume (ECVIC-liver) and chronic liver failure consortium-acute ...
Apr 6, 2023
0
2
Moderate and severe ovarian hyperstimulation syndrome (OHSS) developed in 1.14% of Chinese women of reproductive age between 2013 and 2017. Moreover, women under 35 years of age receiving assisted reproductive technology ...
Mar 24, 2023
0
27
An influenza outbreak in China picked up intensity over the past week as a major city prepared to enforce pandemic-style lockdowns to curb the surge in infections.
Mar 13, 2023
0
34
Recurrent febrile urinary tract infections (FUTIs) are common in children with neurogenic bladder, and the risk for rapid progression to chronic kidney disease (CKD) increases in a dose-response manner, according to a study ...
Mar 8, 2023
0
2
Significant benefits are seen with motavizumab, nirsevimab, and palivizumab for prevention of respiratory syncytial virus (RSV) in infants and children, according to a review published online Feb. 17 in JAMA Network Open.
Mar 7, 2023
0
13
